Credits: Canva
Until law, GLP-1 drugs were used to treat diabetes, obesity and even the recent evidences suggest that it could as well be used to treat chronic kidney problems. There is yet another research, published in JAMA Psychiatry on February 25, titled Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial that explores if GLP-1 receptor agonist semaglutide reduce alcohol consumption and cravings in adults with alcohol use disorder.
The research was conducted over a period of 9 weeks, where in the randomized clinical trial, the participants who were administered semaglutide, it led to reductions in some but not all measures of weekly consumptions. It also reduced weekly alcohol and craving related to placebo, and also led to a greater relative reduction in cigarettes per day.
The research also found that weekly injections of semaglutide, which is the active ingredient in weight loss drugs like Wegovy also helped reduce cravings in people with alcohol use disorder.
The lead author Christian Hendershot said that these findings will help in developing new approaches to treat alcoholism. "Two drugs currently approved to reduce alcohol consumption aren't widely used. The popularity of Ozempic and other GLP-1 receptor agonists increases the chances of broad adoption of these treatments for alcohol use disorder," said Hendershot in news release by the University of Southern California's Institute for Addiction Research, where he is the director.
The study is government-funded research and was funded by the National Institute on Alcohol Abuse and Alcoholism, part of the National Institutes of Health.
The study was small, and took in account for only 48 adults over two months, thus experts say that it is not yet clear how safe these drugs are for people who do not need to lose weight. Though the results do add up with the evidence form animal studies on drugs like Ozempic and Wegovy on how it helps manage cravings, not just for food, but also for tobacco and alcohol. Scientists are also studying these drugs on smokers, people with opioid addiction and cocaine users.
Co-author Dr Klara Klein of the University of North Carolina at Chapel Hill who treats people with obesity and diabetes said, "This is such promising data. And we need more of it. We frequently will hear that once people start these medications that their desire to drink is very reduced, if not completely abolished."
The GLP-1 receptor agonists work by mimicking hormones GLP-1 in the gut and brain that regulates appetite and feelings of fullness. This response is what helps one lose weight, and what helps one curb their craving for alcohol. These drugs that mimic the functioning of your brain, which is responsible to tell your body when to stop consuming, are the same hormones that tell your body about other kinds of consumptions, including alcohol. Therefore by consuming the weight loss drugs one can treat alcohol use disorder.
However, the researchers have pointed out on the limited data on the research and have suggested to continue using the three approved drugs by the National Institute on Alcohol Abuse and Alcoholism and Substance Abuse and Mental Health Services Administration, namely, Disulfiram, Naltrexone, and Acamprosate to treat alcohol use disorder until large studies confirm these findings.
Weight loss drugs can also reduce alcohol cravings. (Photo credit: AI generated)
After a long day at work, the occasional glass of wine helps many people unwind. However, some struggle to strike a balance and get involved in binge drinking habits. If you are someone who is unable to give up that frequent dose of cocktails, then a study claims that weight loss drugs can come to your rescue. Experts have found that alcoholics who are obese, when given Wegovy, could curb their drinking habits by as much as 70 per cent. A study in Denmark was led by experts from the Mental Health Centre Copenhagen and Frederiksberg Hospital, and experts used semaglutide on 108 obese patients seeking treatment for alcohol use disorder.
Half the participants in the study were given 2.4 mg of the drug for six months. The other half were also given a dummy drug. Researchers found that people who were on weight loss drugs had fewer days of binge drinking. Furthermore, their alcohol cravings also dipped compared to people on placebo. Before the trial began, participants engaged in binge drinking on an average of 17 days per month.
Researchers also noted that people who were given semaglutide for six months saw their binge drinking days reduce to five in a 30-day period. This correlated to a 40 per cent dip in drinking days in a month, compared to a 26 per cent dip in the placebo group. These dummy drugs helped reduce drinking days to nine. In terms of alcohol quantity, trial participants drank roughly 2,200 g in the 30 days before the trial started. This meant about 154 drinks in a month, or five per day. Over a period of six months after the trial, there was an impressive 70 per cent dip — from an average of 154 drinks a month to 46 drinks a month in people who were taking semaglutide.
Alcohol consumption dipped by an impressive 47 per cent in the dummy drug group as well. The study found that overall alcohol consumption can be reduced among semaglutide users compared to people who were taking the placebo. Researchers found that semaglutide not only affects appetite but also influences biological mechanisms associated with addiction.
Independent researchers found that the results were encouraging and strong enough to be used in helping people struggling with alcohol use problems. However, more research is required in this area. Researchers also noted that there were no follow-ups with the participants after the semaglutide treatment ended. This means that experts could not be fully certain whether people reverted to their old drinking habits once they stopped using the medicine.
Apart from inducing weight loss, weight loss drugs have the following health benefits:
Credit: Politico
A whopping $600 million global vaccine aid meant for poorer nations has been put on hold by US Health Secretary Robert F. Kennedy Jr., according to a media report.
The delay in vaccines is putting pressure on the international humanitarian group Gavi, the Vaccine Alliance that distributes them, Politico reported.
Gavi noted that it has not received the funds due for the current and previous fiscal years, which account for about 15 percent of its budget.
The funds are set to expire on September 30 if the Trump administration does not release them.
The organization provides vaccines for 20 diseases, including measles, malaria and polio, to more than 50 low-income countries worldwide.
Sania Nishtar, Gavi CEO, told the newswire AFP, the funding gap, combined with reductions from other donors, has particularly impacted malaria vaccination efforts.
Gavi has delivered 39 million doses of a malaria vaccine to 25 African countries, where the disease predominantly affects children under five. Nishtar warned that tens of thousands of children could die as a result of the funding cuts.
Kennedy argues that the shots are obsolete with dangerous ingredients that the US has long since phased out.
“Gavi has refused to provide the United States with the specific data, studies, or detailed accounting of how US funds are used,” Emily Hilliard, senior press secretary at the Health and Human Services Department, said in a statement.
Advocates for Gavi, the Vaccine Alliance warn that withholding funds could cost children’s lives. They argue that the vaccines used are safe and better suited for developing regions, where refrigeration is limited and administering booster doses is more difficult.
Hilliard said Gavi has declined to create a plan to phase out thimerosal, a mercury-based vaccine preservative that Kennedy believes may be linked to autism. The administration has asked Gavi to stop using vaccines containing this preservative.
Thimerosal is used in several vaccines distributed by Gavi, including combination shots protecting against multiple diseases, according to former chief executive Seth Berkley. He explained that many developing countries rely on multi-dose vials, which require less refrigeration but may contain thimerosal to prevent contamination.
Without such vaccines, “kids would go without vaccines… and that would lead directly to deaths,” Berkley said.
During testimony before the Senate Appropriations Committee, Kennedy also raised concerns about a vaccine used to protect against diphtheria, tetanus and pertussis, claiming it had been discontinued in the US due to safety issues.
Gavi responded that the vaccine remains in use because it offers longer-lasting protection and requires fewer doses. The organization said the vaccine “is safe and effective and estimated to have saved 40 million lives in the past 50 years,” the report said.
Plant milk, according to studies, is good for heart patients and even diabetics. (Photo credit: AI generated)
A plant-based diet is highly recommended for a healthy heart — weight watchers can also benefit from it, as can diabetics. When one goes vegan, the biggest change comes when one moves from dairy milk to oat, almond, or soy milk. Parents, too, are now shifting their children to trendy vegan milk options — little do they realise that this could bring their worst fears to life. According to the British Society for Allergy & Clinical Immunology, drinks that are aimed at children and often marketed as healthy are usually loaded with sugar and offer little or no nutrition.
Experts found that children under five years of age are more prone to malnutrition, tooth decay, or even obesity. The study is the first of its kind, and its warning will be published in the coming week. It is backed by the British Dental Association and the British Dietetic Association. Doctors say that plant-based drinks are often compared to cow’s milk in terms of nutrition. However, these claims are not supported by current evidence.
Plant milk has gained popularity in recent years because of the health benefits that many believe it offers. While adults may benefit from it in several ways, toddlers must not be given these packaged, sugary drinks. The added sugars can become nothing more than a frequent treat for children, who may lose their milk teeth sooner and suffer from decay. Researchers found that families are often convinced that plant milk is good for children, but these oat, almond, and soy versions of milk are processed and full of sucrose and fructose syrups.
According to a report, most of these drinks contain large amounts of sugar in the form of maltodextrin, glucose syrup, sucrose, and fructose. A 350 ml glass of such milk contains more than double a toddler’s daily sugar allowance. Ideally, toddlers should not be given more than 14 grams of sugar every day. Their young bodies can struggle to absorb vitamin B12 and calcium from plant drinks. The BSACI recommends that parents opt for unsweetened, fortified plant milk instead, as these can play a crucial role in supporting children’s health.
Ultra-processed foods (UPFs) are defined as food groups that undergo a great deal of processing — the most natural foods fall under Group 1, while heavily processed foods are placed under Group 4. While these do not definitively determine how healthy a food option is, they indicate the level of processing involved. Highly processed foods are associated with a range of health problems, which is why it is important to make informed dietary choices.
In your kitchen, foods with a minimal level of processing include:
Some of the most processed foods in your kitchen include:
© 2024 Bennett, Coleman & Company Limited